Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes

Publication | Closed Access

DOI

297

Citations

References

2008

Year

Christopher P. Cannon, Robert P. Giugliano, Michael A. Blazing, Robert A. Harrington, John L. Peterson, Christine McCrary Sisk, John Strony, Carolyn H. McCabe, Enrico P. Veltri, Eugene Braunwald,

American Heart Journal

ThrombosisCardiovascular DiseaseCardiovascular OutcomesImproved ReductionClinical TrialsOutcomes ResearchPharmacotherapyPublic HealthMedicineCardiologyAcute Coronary SyndromesCoronary Artery DiseaseAcute Myocardial InfarctionMyocardial Infarction